Prevalence of Hepatitis B in Vallés Occidental. Observational Multicentric Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 1,001
- 试验地点
- 1
- 主要终点
- prevalence hepatitis B
研究概览
简要总结
The aim of this study is to evaluate the prevalence of hepatitis B in Vallés Occidental. Also, describe the stage of the disease, and whether if they are under medical treatment or not.
详细描述
The hepatitis B virus ( HBV ) is a global health problem . It is estimated that in the world there are about 350-400 million carriers of HBV surface antigen ( HBsAg ) 1 .
The prevalence in Spain is estimated at a 2-7 % and is considered a second intermediate prevalence.
For over 20 years, has carried out a program of primary prevention through universal vaccination against hepatitis B including it in the childhood vaccination schedule and has already been observed that in some estudi3 the prevalence has declined . For this reason , we want to evaluate what is the currently prevalence in our area of influence. There aren't recent studies to assess what is the current status of these patients ( how many , what risk factors which needs of treatment and with answer ...)
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with HBsAg + visited in Digestive/Hepatology outpatient visits and Hepatology of the participating hospitals
排除标准
- •Patients < 18 aged
- •Duplicity on record
结局指标
主要结局
prevalence hepatitis B
时间窗: 12 months
次要结局
- stage of the disease and if they are in treatment or not(1 day)
研究者
Mireia Miquel-Planas
phD
Corporacion Parc Tauli